• Screen for an immune response following COVID-19 infection or vaccination
  • A testing solution for multiple scenarios: workplace testing, border control or vaccine rollout
  • Results in 20 minutes from a small blood sample
  • Sensitivity: 98.03%, Specificity: 99.56% 

*The SARS-CoV-2 spike protein is integral in initiating infection. Neutralising IgG antibodies target the SARS-CoV-2 Spike protein and therefore interfere with the virus’ ability to enter human cells.

Contact us
AbC-19-box-25-kit 720×500-01

Why use AbC-19™ Rapid Antibody Test?

  • A powerful tool for limiting risks and helping governments, individuals and businesses make more informed decisions about COVID safety and vaccine programmes
  • CE marked for use by professionals or trained lay users (training available)
  • Easy to use and requires minimal training
  • Convenience with less frequent testing and no requirement to swab
  • Option to add the AbC-19™ semi-quantative score-card to indicate the strength of the antibody response
  • 24/7 international customer support helpline
  • App certification technology available upon request
  • Instructions in multiple languages

Why choose AbC-19™?

  • Validate vaccine certificates for inbound border controls and large events
  • Screen for IgG neutralising antibodies pre- and post-vaccine rollout
  • Determine IgG neutralising antibody status post-infection
  • Allow individuals to determine and monitor their COVID-19 antibody status
  • Strengthen and reassure COVID-safety strategies in workplaces, schools and universities
  • Support SARS-CoV-2 serological studies

Who should use AbC-19™?

  • Airlines and Airports
  • Border control
  • Events organisers
  • Governments
  • Healthcare agencies
  • Pharmacies
  • Researchers
  • Seaports
  • Workplaces

Order enquiries and distributor requests

Speak with a member of our AbC-19™ team today.

Contact Us

Frequently Asked Questions

  • AbC-19™ is a lateral flow antibody test. From a finger-prick sample of blood, AbC-19™ antibody rapid test detects the SARS-CoV-2 IgG neutralising antibodies to the full trimeric spike protein produced in response to the virus or following vaccination.

    The rapid antibody test will determine if the body has produced a measurable immune response indicating a previous infection with COVID-19 virus or a response to vaccination. It will not confirm if you are currently infected by the virus.

  • The body produces antibodies targeting specific parts of the SARS-CoV-2 (COVID-19) virus with the Nucleocapsid protein and the Spike protein being of importance in the context of antibody tests. The coronavirus nucleocapsid protein is a multi-functional protein whereas the spike protein is integral in penetrating human cells and initiating infection.

    Neutralising IgG antibodies target the SARS-CoV-2 Spike protein and interfere with the virus’ ability to enter human cells. IgG antibodies are the most common antibody in blood and have a large part to play in conferring immunity to bacteria or viruses.

    • Healthcare professionals, such as doctors, nurses, pharmacists and healthcare workers.
    • Laboratory professionals
    • Trained lay providers in workplaces, schools or universities for example. (Training packages available. Contact our team)

    This SARS-CoV-2 IgG antibody test is CE marked and meets UK and European Union (EU) health and safety requirements.

    • AbC-19™ must be administered and interpreted by a healthcare profession or a trained lay person.
    • Training for lay users can be provided remotely (Duration: 1-2 hours).
    • Following successful completion a certificate is provided confirming the lay user as a professional user for a period of 12 months.

    Contact our team

  • A positive result with AbC-19™ Rapid Test confirms the presence of neutralising IgG antibodies to the full trimeric spike protein of the SARS-CoV-2 virus. This is an indicator that someone has produced an immune response following COVID-19 infection or vaccination.

  • The line closest to the sample hole is the test line (T-line). The presence of a T-line alongside a C-line is a POSITIVE result, the absence of a T-Line alongside a C-line is a NEGATIVE result.

  • 25 x AbC-19™ Rapid Tests
    30 x Lancets
    30 x Test Solution Vials (containing 30 units)
    30 x Blood Collectors
    25 x Waste Bags
    1 x IFU (Instructions for Use)

  • For assistance when using and interpreting AbC-19™ please contact our helpline:
    Tel: +44 (0) 2890 394 258
    Email: abc19support@mplcontact.com

    Support lines are open 24 hours, seven days a week

    Note: questions about ordering or quotations must be directed to customerservices@abingdonhealth.com.

  • Payment accepted in GBP (£), USD ($) and EUR (€) via BACS, Credit Card or Debit Card. Orders can be placed via +44 (0) 1904 406082 or email info@abingdonhealth.com.

    Delivery timelines depend on order size and shipping locations. Shipping costs are in addition to the cost of the tests and calculated before despatch. All orders are tracked.

  • AbC-19™ was developed by global lateral flow manufacturer, Abingdon Health, on behalf of the UK Rapid Test Consortium (UK-RTC). Led by Abingdon Health, the AbC-19™ COVID-19 IgG antibody test is manufactured across several UK sites.

    • Manufactured under ISO 9001 and ISO 13485

    Our quality standards.

  • Upon request, the AbC-19TM Rapid Test can be used with an App in order to produce a antibody certificate.

    Professionals or trained lay users operate the App and send a COVID-19 antibody certificate to a patient’s Smartphone.

    Below explains how to use the AbC-19TM Antibody Test App.

    • A professional or trained lay user downloads
    • Input standard patient details and take a picture of the patient
    • Scan the barcode on the AbC-19TM Rapid Test kit box for traceability reasons
    • Carryout the AbC-19TM Rapid Test
    • The App will then time the test incubation (20 minutes)
    • Capture an image of the test
    • Confirm the test result in the App
    • Share the result and certificate with the patient in various ways:
      • QR code
      • SMS
      • Email

    Each certificate has unique QR code that can be scanned with no special Apps required. A patient can then present the certificate containing the QR Code for antibody status validation. Once scanned a picture of the patient and test results will be displayed within the certificate.

    The App is powered by Novarum™️ technology.